UK Explained
Bills · Became law

Rare Cancers Act 2026

The bill has been signed off by the King and is now law.

In plain words

This law aims to encourage research into treatments for rare cancers. It requires a review of how medicines for rare conditions are licensed, and creates a national lead to promote research on rare cancers.

Summary drafted by AI, checked by Jonathan on 4 Oct 2026. Source: Parliament Library briefing.

Official title: Rare Cancers Act 2026

  1. 1Introduced1st reading
  2. 2Main debate2nd reading
  3. 3Detailed checksCommittee
  4. 4ChangesReport stage
  5. 5Final vote3rd reading
  6. 6Other houseLords or Commons
  7. 7Becomes lawRoyal Assent

Nothing more. This bill is now law.

Put forward by Dr Scott Arthur, Julie Elliott.

Votes so far

No Commons votes on this bill in the last 12 months.

Full timeline
DateStageHouse
16 Oct 20241st readingCommons
14 Mar 20252nd readingCommons
30 Jun 2025Money resolutionCommons
2 Jul 2025Committee stageCommons
11 Jul 2025Report stageCommons
11 Jul 20253rd readingCommons
14 Jul 20251st readingLords
16 Jan 20262nd readingLords
11 Feb 2026Order of Commitment dischargedLords
27 Feb 20263rd readingLords
5 Mar 2026Royal AssentUnassigned

In the bill’s own words: A Bill to make provision to incentivise research and investment into the treatment of rare types of cancer; and for connected purposes.

Official page on Parliament’s site

Source: Parliament Bills API · Commons votes from the Commons Votes API.